CAPHRA urges THR evidence review before COP10

Dec.12.2022
CAPHRA urges THR evidence review before COP10
CAPHRA urges tobacco control representatives to review evidence supporting harm reduction methods before COP10.

The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has written letters to the heads of various tobacco-control framework convention delegations urging them to review evidence supporting tobacco harm reduction (THR) methods before COP10.


As governments from around the world send delegates to COP10 in November 2023, CAPHRA is eager to provide comprehensive reference materials to leaders for their planning, submission writing, and review processes.


The 10th Conference of Parties (COP10) will be held in Panama and will be hosted by the World Health Organization's Framework Convention on Tobacco Control.


We, on behalf of the 4 million users in the Asia-Pacific region who currently utilize safer nicotine products, are taking this action. As you may be aware, our region is particularly vulnerable to the harm and deaths caused by combustible and unsafe oral tobacco.


Representatives from CAPHRA have reminded healthcare leaders that the FCTC has the authority to make harm reduction a core tobacco control policy.


For decades, it has been widely accepted that tar and carcinogenic substances found in tobacco smoke are responsible for smoking-related deaths and illnesses, rather than nicotine. Studies have shown that while nicotine can be mildly addictive, similar to caffeine, it is not a health concern, according to the authors.


The letter also calls on representatives to condemn the policy of holding the COP10 conference of the FCTC behind closed doors.


Representatives attending COP10 are expected to represent the rights and wishes of their citizens, whose taxes are funding their attendance. Citizens expect their representatives to speak on their behalf, recognize the scientific support for reducing harm through ENDS, and uphold democratic principles, the letter stated.


CAPHRA representatives are calling on countries to consider consumers' right to make choices that can help them avoid negative health outcomes when submitting their COP10 statements. It is crucial that smokers have access to nicotine products with less harmful effects as alternatives to smoking.


At the fifth Asia Harm Reduction Forum, CAPHRA's executive coordinator Nancy Loucas presented a recently released white paper titled "Disrupting Public Health: A Consumer Perspective," which is based on evidence.


2FIRSTS will continue to cover this topic and provide updates on our mobile application, '2FIRSTSAPP.' Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. Federal Judge Rejects Flavored Vape Maker’s Appeal, Upholds New York City Enforcement
U.S. Federal Judge Rejects Flavored Vape Maker’s Appeal, Upholds New York City Enforcement
On July 15, 2025, a Manhattan federal judge denied a motion to dismiss New York City’s lawsuit against eight e-cigarette wholesalers accused of illegally selling flavored vapes. The court affirmed the city’s right to sue and upheld its claims.
Jul.16 by 2FIRSTS.ai
China Tobacco Deputy Administrator Liu Sanjiang Meets with BMJ CEO Huang Tianle
China Tobacco Deputy Administrator Liu Sanjiang Meets with BMJ CEO Huang Tianle
On July 15, Liu Sanjiang, Deputy Administrator of the State Tobacco Monopoly Administration, met with BMJ CEO Huang Tianle in Beijing for a cordial discussion. Heads of several departments from the administration also attended the meeting.
Jul.16 by 2FIRSTS.ai
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs said its e-cigarettes have received FDA marketing granted orders (MGOs), meeting the “public health” standard. It noted it is the only major vaping firm not backed by a traditional tobacco company.
Jul.18
KT&G Plans $200 Million Acquisition of Nordic Pouch Company
KT&G Plans $200 Million Acquisition of Nordic Pouch Company
KT&G is considering acquiring a Nordic nicotine pouch maker for about KRW 300 billion (USD 200 million), its largest overseas deal since 2011, according to sources. The move aims to boost its oral nicotine portfolio as cigarette sales decline and regulations tighten. KT&G declined to comment, saying no decision has been finalized.
Jun.04 by 2FIRSTS.ai
Nepal High Court Rules to Lift Ban on E-cigarette Import and Sales
Nepal High Court Rules to Lift Ban on E-cigarette Import and Sales
Nepal’s Patan High Court ruled to lift the ban on e-cigarette imports and sales, stating the Health Ministry’s directive lacked legal basis. In 2023–2024, e-cigarette imports generated over NPR 230 million (about $1.73 million) in customs revenue.
Jul.03 by 2FIRSTS.ai
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
STMA Launches Special Inspection: Shenzhen Vape Companies Face Major License Renewal Test
Shenzhen office of the State Tobacco Monopoly Administration (STMA) announced the launch of a month-long special inspection targeting local vape companies.
Jun.12